← Leaderboards
John F Cipollo
Boston University Medical Campus
$293,776
Attributed
$293,776
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $113.1K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$293,776 · 12
By mechanism
P41$208,660 · 11
F32$85,116 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Louis Vernacchio$1,296,901
- Timothy E McAlindon$15,710,823
- Geetha Sugumaran$620,027
- Carlos Benjamin Hirschberg$4,785,154
- Catherine E. Costello$27,592,140
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthResearch PersonnelResourcesComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionPolysaccharidesGrantSourceFundingComplexSpectrum Analysis, MassPeptide N-Glycohydrolase FMannoseCaenorhabditis ElegansOligosaccharidesGlycosylationMutantChitobioseChargeBos TaurusCattleCostCarbonAmidohydrolases
Grant awards (13)
LC/MS APPROACH FOR THE ANALYSIS OF PERMETHYLATED OLIGOSACCHARIDE ALDITOLS$41,484
P41 · FY2008 · RR · contact PI
CAENORHABDITIS ELEGANS AS A MODEL FOR GLYCOMICS$25,922
P41 · FY2008 · RR · contact PI
PURIFICATION OF PEPTIDE-N4-(N-ACETYL-BETA-D-GLUCOSAMINYL)ASPARAGINE AMIDASE F$650
P41 · FY2008 · RR · contact PI
LC/MS APPROACH FOR THE ANALYSIS OF PERMETHYLATED OLIGOSACCHARIDE ALDITOLS$68,950
P41 · FY2007 · RR · contact PI
CAENORHABDITIS ELEGANS AS A MODEL FOR GLYCOMICS$43,094
P41 · FY2007 · RR · contact PI
PURIFICATION OF PEPTIDE-N4-(N-ACETYL-BETA-D-GLUCOSAMINYL)ASPARAGINE AMIDASE F$1,077
P41 · FY2007 · RR · contact PI
CAENORHABDITIS ELEGANS AS A MODEL FOR GLYCOMICS$7,730
P41 · FY2006 · RR · contact PI
PURIFICATION OF PEPTIDE-N4-(N-ACETYL-BETA-D-GLUCOSAMINYL)ASPARAGINE AMIDASE F$4,393
P41 · FY2006 · RR · contact PI
CAENORHABDITIS ELEGANS AS A MODEL FOR GLYCOMICS$7,710
P41 · FY2005 · RR
PURIFICATION OF PEPTIDE-N4-(N-ACETYL-BETA-D-GLUCOSAMINYL)ASPARAGINE AMIDASE F$4,382
P41 · FY2005 · RR
Characterization of the C. elegans N- and O-glycomes$47,296
F32 · FY2004 · GM
ANALYSIS OF HOST-PATHOGEN INTERACTIONS USING C. ELEGANS$3,268
P41 · FY2004 · RR
Characterization of the C. elegans N- and O-glycomes$37,820
F32 · FY2002 · GM